HIV
Conference Coverage
Dolutegravir passes late pregnancy test
SEATTLE - In ART-naive women in the third trimester of pregnancy, dolutegravir led to reduced viral load at delivery compared to efavirenz.
Conference Coverage
Weight gain highest with integrase inhibitors for HIV
SEATTLE –
News from the FDA/CDC
FDA approves first two-drug tablet for HIV
Conference Coverage
Nucleic acid testing before PrEP urged to detect occult HIV
SEATTLE – As PrEP becomes more common, fears of increasing HIV drug resistance become a greater concern.
Conference Coverage
PrEP adherence lowest among Medicaid patients, others
Conference Coverage
Harness EHRs to identify PrEP candidates
Conference Coverage
Genetic data boost HIV surveillance efforts
SEATTLE –
Conference Coverage
STIs pose complex challenge to HIV efforts
SEATTLE – ...
Conference Coverage
Noninfected children of HIV-positive mothers have high rates of obesity
NEW ORLEANS – Obesity and reactive airway disease are more prevalent in noninfected children of HIV-positive mothers.
Conference Coverage
One HCV infection leads to another in HIV+ MSM
Conference Coverage
Long-acting injectables noninferior to tablet integrase for HIV
SEATTLE – Monthly injections were preferred by 98%-99% of participants over oral drugs.